Zhongyuan Xiehe (600645.SH) and related personnel received a warning letter measure.

Zhitong Finance APP News, Zhongyuan Xiehe (600645.SH) issued an announcement that on September 15, 2026, the company received the "Decision on Taking Measures of Issuing Warning Letters against Zhongyuan Xiehe Cell Gene Engineering Co., Ltd., Gong Hongjia, WANG HONGQI (Wang Hongqi), and Chen Yiqing" issued by the Tianjin Regulatory Bureau of the China Securities Regulatory Commission. Upon investigation, the company announced in July 2025 that it had signed a real estate lease contract with related party Shanghai Yanli Biotechnology Co., Ltd. (hereinafter referred to as Shanghai Yanli), leasing real estate from Shanghai Yanli for the purpose of establishing an East China headquarters and coordinating resource allocation. The company's strategic planning demonstration for establishing the East China headquarters was insufficient, not rigorous, and lacked sufficient basis, and the reasonableness and necessity of the lease were insufficient. The information disclosed in the above related-party transaction of leasing real estate from Shanghai Yanli was untrue and inaccurate, violating the provisions of Article 3, Paragraph 1 of the "Measures for the Administration of Information Disclosure by Listed Companies" (CSRC Order No. 226).